Strategy

SurgeryTech has developed and introduced a new medical single-use device for both laparoscopic or/and thoracoscopic single-port procedures. Its benefits and values have been demonstrated, and it is foreseen that the KatScope method will be the preferred method for both laparoscopic or/and thoracoscopic single-port procedures in the future.

SurgeryTech Aps, a privately owned company controlled by inventors, is now looking for partners and/or organisations who are able to bring the KatScope to the market.

The KatScope project is offered for sale to a third party e.g. as an asset deal with an up-front payment (primary) and a royalty- bearing agreement (secondary) or as a one-off deal structure.

The inventors offer, as a separate agreement, to assist the acquiring party under a consultancy agreement.

Further information/documents can be forwarded after signing of a CDA.